M&A

Thermo Fisher's pharma head talks Brammer Bio and future M&A
Biopharma Dive
Thu, 03/28/19 - 07:56 pm
Thermo Fisher
M&A
Brammer Bio
Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition
BioSpace
Thu, 03/28/19 - 12:06 pm
AstraZeneca
Aveo Oncology
M&A
Philips buys Direct Radiology
Mass Device
Wed, 03/27/19 - 11:06 pm
Philips
devices
M&A
Direct Radiology
teleradiology
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
TheStreet.com
Tue, 03/26/19 - 09:44 am
SEC
FTC
M&A
Bristol-Myers Squibb
Celgene
Allergan taps Celgene vet Hugin for M&A guidance, but proxy brawlers aren't impressed
Fierce Pharma
Mon, 03/25/19 - 10:32 pm
Allergan
investors
M&A
Bob Hugin
Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues
Xconomy
Mon, 03/25/19 - 10:27 am
Thermo Fisher
Brammer Bio
M&A
gene therapy
2 Biotech Takeout Targets Perfect for Biogen
Motley Fool
Sat, 03/23/19 - 12:11 pm
Biogen
M&A
SAGE Therapeutics
Neurocrine Biosciences
Where can Biogen turn after mammoth Alzheimer's blow? The M&A table, analysts say
Fierce Pharma
Thu, 03/21/19 - 12:28 pm
Biogen
Alzheimer's disease
aducanumab
M&A
Could proxy advisors sway investors to vote ‘no’ on BMS-Celgene merger?
Fierce Pharma
Thu, 03/21/19 - 12:17 pm
Bristol-Myers Squibb
Celgene
investors
M&A
Brainlab Makes Huge Push into Robotics with Medineering Deal
Medical Devices and Diagnostics Industry
Wed, 03/20/19 - 08:10 pm
Brainlab
Medineering
robotics
devices
M&A
Pfizer buys stake in French gene therapy firm Vivet
CNBC
Wed, 03/20/19 - 09:57 am
Pfizer
M&A
Vivet
gene therapy
liver disease
Gene therapy progress spurs competition in biotech buyouts
Biopharma Dive
Tue, 03/19/19 - 11:41 pm
biotech
gene therapy
M&A
Biogen
Nightstar Therapeutics
Roche
Spark Therapeutics
Bayer animal health sale could rake in $8B and bids from private equity: report
Fierce Pharma
Tue, 03/19/19 - 11:31 am
Bayer
animal health
M&A
Bristol-Myers and Starboard Value spar over $74B Celgene buyout as shareholder vote looms
Endpoints
Tue, 03/19/19 - 10:37 am
Bristol-Myers Squibb
Starboard
Celgene
M&A
Partnering talks led to Biogen’s $800M Nightstar buyout as players clustered around the hot deal table for gene therapies
Endpoints
Mon, 03/18/19 - 11:48 pm
Biogen
gene therapy
Nightstar Therapeutics
M&A
Novartis’ Alcon picks up PowerVision for $285m
Mass Device
Mon, 03/18/19 - 05:09 pm
Novartis
Alcon
PowerVision
M&A
interocular lens
devices
Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
Motley Fool
Fri, 03/15/19 - 11:55 pm
M&A
Bristol-Myers Squibb
Celgene
CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Thu, 03/14/19 - 10:06 am
Novartis
Sandoz
generics
M&A
Richard Francis
biosimilars
Stryker pays up to $220m for OrthoSpace
Mass Device
Thu, 03/14/19 - 09:54 am
Stryker
OrthoSpace
M&A
devices
How This Looming Patent Battle Could Challenge Bristol-Celgene Deal
Investors Business Daily
Wed, 03/13/19 - 10:13 am
Celgene
Novartis
ozanimod
MS
multiple sclerosis
patents
Bristol-Myers Squibb
M&A

Pages